T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$2.42B |
| 2 |
Wynn Resorts
WYNN
|
+$992M |
| 3 |
Eli Lilly
LLY
|
+$964M |
| 4 |
Visa
V
|
+$700M |
| 5 |
American Airlines Group
AAL
|
+$626M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$1.24B |
| 2 |
Dollar Tree
DLTR
|
+$1.13B |
| 3 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$1.03B |
| 4 |
Gilead Sciences
GILD
|
+$792M |
| 5 |
ROC
ROCKWOOD HLDGS INC
ROC
|
+$788M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.72% |
| 2 | Consumer Discretionary | 13.88% |
| 3 | Financials | 12.99% |
| 4 | Industrials | 12.02% |
| 5 | Technology | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EPZM
1176
DELISTED
Epizyme, Inc
EPZM
| $15.9M | ﹤0.01% |
585,771
+61,240
| +12% | +$1.9M |
|
1177
NVIDIA
NVDA
$5.47T
| $15.8M | ﹤0.01% |
34,334,240
-2,920,000
| -8% | -$1.38M |
|
|
SNMX
1178
DELISTED
Senomyx, Inc.
SNMX
| $15.6M | ﹤0.01% |
1,906,865
-41,300
| -2% | -$329K |
|
1179
BlackRock TCP Capital
TCPC
$343M
| $15.6M | ﹤0.01% |
971,225
+4,800
| +0.5% | +$83.1K |
|
1180
Infosys
INFY
$49.4B
| $15.5M | ﹤0.01% |
2,053,720
+68,048
| +3% | +$490K |
|
1181
Utah Medical Products
UTMD
$229M
| $15.5M | ﹤0.01% |
317,440
+250
| +0.1% | +$12.7K |
|
|
GRA
1182
DELISTED
W.R. Grace & Co.
GRA
| $15.4M | ﹤0.01% |
169,370
+1,580
| +0.9% | +$151K |
|
|
ZSPH
1183
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
| $15.4M | ﹤0.01% |
+391,800
| New | +$12.9M |
|
|
HPY
1184
DELISTED
HEARTLAND PAYMENT SYSTEMS, INC. COM STK
HPY
| $15.2M | ﹤0.01% |
319,135
-4,200
| -1% | -$195K |
|
1185
CBRE Group
CBRE
$43.8B
| $15.2M | ﹤0.01% |
510,345
-1,900
| -0.4% | -$59.7K |
|
|
PNNT
1186
Pennant Park Investment Corp
PNNT
$244M
| $15.1M | ﹤0.01% |
1,385,740
-276,132
| -17% | -$3.18M |
|
1187
Best Buy
BBY
$18.5B
| $15.1M | ﹤0.01% |
449,799
+5,600
| +1% | +$176K |
|
1188
Unum
UNM
$14.8B
| $15M | ﹤0.01% |
437,558
-1,710
| -0.4% | -$60.1K |
|
1189
Ashland
ASH
$3.37B
| $15M | ﹤0.01% |
294,612
+227,593
| +340% | +$11.9M |
|
|
CMA
1190
DELISTED
Comerica
CMA
| $15M | ﹤0.01% |
300,221
-10
| -0% | -$501 |
|
|
NHC.PRA
1191
DELISTED
NATIONAL HEALTHCARE CORP PFD CONV SER A (DE)
NHC.PRA
| $15M | ﹤0.01% |
987,817
-4,600
| -0.5% | -$69.6K |
|
1192
Copa Holdings
CPA
$6.2B
| $14.9M | ﹤0.01% |
139,200
-27,095
| -16% | -$3.61M |
|
|
CLNY
1193
DELISTED
Colony Capital, Inc.
CLNY
| $14.9M | ﹤0.01% |
667,250
-300
| -0% | -$6.75K |
|
1194
Navigator Holdings
NVGS
$1.29B
| $14.9M | ﹤0.01% |
535,700
-8,600
| -2% | -$250K |
|
1195
ENI
E
$79.8B
| $14.8M | ﹤0.01% |
313,200
+276,500
| +753% | +$14M |
|
|
PENX
1196
DELISTED
PENFORD CORP
PENX
| $14.7M | ﹤0.01% |
1,119,100
-900
| -0.1% | -$11.7K |
|
1197
Euronet Worldwide
EEFT
$2.75B
| $14.7M | ﹤0.01% |
308,350
+3,500
| +1% | +$174K |
|
1198
Sprott Physical Gold and Silver Trust
CEF
$8.28B
| $14.7M | ﹤0.01% |
1,196,070
+2,000
| +0.2% | +$27.5K |
|
1199
RE/MAX Holdings
RMAX
$278M
| $14.7M | ﹤0.01% |
493,240
-286,800
| -37% | -$8.54M |
|
1200
Fortune Brands Innovations
FBIN
$5.72B
| $14.6M | ﹤0.01% |
416,201
-23,437
| -5% | -$819K |
|
Similar funds
T. Rowe Price Associates's Q3 2014 Portfolio in Review
As of Q3 2014, T. Rowe Price Associates held 2,614 positions worth $458B, down 1% from $463B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q3 2014 filing shows 88 new, 949 increased, 837 reduced and 73 closed positions. Its largest new stake was Alibaba: 26,922,443 shares worth $2.39B. The largest sale was PepsiCo, an estimated $1.24B.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q3 2014 buy was Alibaba: 26,922,443 shares worth $2.39B.
- T. Rowe Price Associates added most to Wynn Resorts in Q3 2014, an estimated $992M increase.
- T. Rowe Price Associates's biggest Q3 2014 reduction was PepsiCo, cutting an estimated $1.24B.
- T. Rowe Price Associates fully exited ROCKWOOD HLDGS INC in Q3 2014, selling an estimated $788M.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $458B portfolio in Q3 2014.
- T. Rowe Price Associates opened 88 new positions and closed 73 in Q3 2014.
- T. Rowe Price Associates's portfolio value fell 1% quarter-over-quarter to $458B.
Based on T. Rowe Price Associates's 13F filing for Q3 2014, filed 14 Nov 2014.